MRONJ: Risk Factors, Treatments and Concerns
MRONJ (medication-related osteonecrosis of the jaw) is commonly associated with drugs that prevent bone resorption, such as bisphosphonates, and RANK ligand (RANKL) inhibitors such as denosumab. These drugs are used to treat osteoporosis or cancer that has metastasized to the bone and can interfere with the jawbone’s ability to heal properly after invasive dental procedures […]
Continue Reading